Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administratio (Q41905640)
Jump to navigation
Jump to search
scientific article published on 9 January 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administratio |
scientific article published on 9 January 2009 |
Statements
Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior (English)
Yu-Jun Wang
Yi-Min Tao
Fu-Ying Li
Yu-Hua Wang
Xue-Jun Xu
Jie Chen
Ying-Lin Cao
Zhi-Qiang Chi
Ao Zhang